Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Azelastine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Azelastine 0.05% eye drops
1104020W0AAAAAA
|
Azelastine hydrochloride (Eye) | Azelastine hydrochloride | Eye | 18,677 |
|
Azelastine 140micrograms/dose nasal spray
1202010A0AAABAB
|
Azelastine hydrochloride (Nasal) | Azelastine hydrochloride | Ear, Nose and Oropharynx | 16,420 |
|
Rhinolast 140micrograms/dose nasal spray
1202010A0BBABAB
|
Rhinolast | Azelastine hydrochloride | Ear, Nose and Oropharynx | 2,738 |
|
Optilast 0.05% eye drops
1104020W0BBAAAA
|
Optilast | Azelastine hydrochloride | Eye | 2,302 |
|
Azelastine 210micrograms/dose nasal spray
1202010A0AAAEAE
|
Azelastine hydrochloride (Nasal) | Azelastine hydrochloride | Ear, Nose and Oropharynx | 524 |
|
Azelair 0.15% nasal spray
1202010A0BDAAAE
|
Azelair | Azelastine hydrochloride | Ear, Nose and Oropharynx | 228 |
|
Aller-Eze 0.05% eye drops
1104020W0BCAAAA
|
Aller-eze (Eye) | Azelastine hydrochloride | Eye | No data available |
|
Aller-Eze 140micrograms/dose nasal spray
1202010A0BCAAAB
|
Aller-eze (Nasal) | Azelastine hydrochloride | Ear, Nose and Oropharynx | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.